HeartWare to go OS
05 August, 2008 by Dylan Bushell-EmblingHeartWare to transfer corporate responsibility to US
Streamline for QRxPharma
05 August, 2008 by Dylan Bushell-EmblingFDA approves QRxPharma's streamlined testing protocol
Minomic says no to Probiomics
31 July, 2008 by Kate McDonaldMinomic has withdrawn from a proposed merger with Probiomics
Hexima puts up its defensins
31 July, 2008 by Dylan Bushell-EmblingHexima releases details of field trials against common crop fungal pathogens
Portland denies patent infringement
31 July, 2008 by Dylan Bushell-EmblingSydney prosthetics companies in hip cup barney
OMI heads north again
31 July, 2008 by Dylan Bushell-EmblingOMI finds Canadian distribution partner for safety syringes
Biota completes new flu trial
31 July, 2008 by Dylan Bushell-EmblingPhase II trials of long-acting compound conclude, Phase III next
Innovation review extended
31 July, 2008 by Kate McDonaldDeadline for Innovation Review green paper extended by a month
ASCC board sacks Livesey
31 July, 2008 by Kate McDonaldStephen Livesey has "departed" the ASCC over difference with board
AtCor's pressure rises
30 July, 2008 by Dylan Bushell-EmblingExcellent sales results reported by AtCor
Lancet for Prana
30 July, 2008 by Dylan Bushell-EmblingLancet Neurology publishes Prana's PBT2 trial results
Oncaidia's best practice
30 July, 2008 by Dylan Bushell-EmblingOncaidia wins award Frost & Sullivan award for Apomab technology
Mayo specialist for Cytopia
30 July, 2008 by Dylan Bushell-EmblingCytopia appoints clinical trial chair
Pond scum and the biofuel revolution
29 July, 2008 by Staff WritersMurdoch Uni wins grant to research turning algae into energy
Heaves hit for Stirling
29 July, 2008 by Dylan Bushell-EmblingStirling wins patent for equine heaves treatment
